Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-finding of romiplostim in Japanese ITP
NCT00305435Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Feb 2006
- Primary completion
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, open-label trial of romiplostim in immune thrombocytopenic purpura (ITP) (3 arms), sponsored by Kyowa Kirin. Primary endpoint: Incidence of all adverse events including evaluation of antibody status at 1 year. Started Feb 2006; status: completed.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on NCT00305435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305435.